Literature DB >> 14508228

Thalidomide in Crohn disease and the risk of peripheral neuropathy.

M Ahmed, S El-Hadi, H R Jenkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14508228     DOI： 10.1097/00005176-200310000-00023

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  4 in total

1.  A new opportunity for thalidomide? Further randomised controlled trial are necessary.

Authors:  Federico Marchetti; Marzia Lazzerini; Alessandro Ventura
Journal:  Eur J Clin Pharmacol       Date:  2004-09-03       Impact factor: 2.953

2.  Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition.

Authors:  D G Binion; M F Otterson; P Rafiee
Journal:  Gut       Date:  2008-07-02       Impact factor: 23.059

Review 3.  Thalidomide for inflammatory bowel disease: Systematic review.

Authors:  Matteo Bramuzzo; Alessandro Ventura; Stefano Martelossi; Marzia Lazzerini
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 4.  Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.

Authors:  Carlotta Spagnoli; Francesco Pisani; Francesco Di Mario; Gioacchino Leandro; Federica Gaiani; Gian Luigi De' Angelis; Carlo Fusco
Journal:  Acta Biomed       Date:  2018-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.